JF Apex Securities Research had derived a fair value of RM1 for Rhone Ma based on a 33% upside from the listing price of 75 sen. Its valuation was pegged at 12 times FY17 earnings per share (EPS) forecast of 8.4 sen.
“Our target price-to-earnings ratio assigned is at the higher range of valuation for small cap stocks.
“We feel the valuation is fair given its favourable position in the animal health and nutrition market with 5.9% market share” it added.
Mgician JF Apex Securities Research had derived a fair value of RM1 for Rhone Ma based on a 33% upside from the listing price of 75 sen. Its valuation was pegged at 12 times FY17 earnings per share (EPS) forecast of 8.4 sen.
“Our target price-to-earnings ratio assigned is at the higher range of valuation for small cap stocks.
“We feel the valuation is fair given its favourable position in the animal health and nutrition market with 5.9% market share” it added.
20/12/2016 16:46 --------------------------------------------------- it's time to realize profit ???
Personally, I'm keeping this share. Bought some below 90 cents. RM1 is considered fair but I do believe in this company's potential. Should increase gradually over time. Personal opinion. I'm no expert.
I agree with RIAZ. It is another Dancomech. Do a comparison with Dancomech and then you will realize both are about same style. Today lowest RM0.955 and final hour you will see someone pushed it back to RM0.985. Closing down half cent today, RM0.98. Target price is RM1.50 in medium term. Good luck!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
jha199
9 posts
Posted by jha199 > 2016-12-19 09:45 | Report Abuse
yess
1